Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronomic Therapy in Recurrent Neuroblastoma
NCT02641314Phase 2Completed
- Sponsor
- University of Cologne
- Start
- Dec 2016
- Primary completion
- Jun 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of propranolol, celecoxib, cyclophosphamide, etoposide, vinblastine in neuroblastoma, sponsored by University of Cologne. Started Dec 2016; status: completed.
02
Drugs
propranololcelecoxibcyclophosphamideetoposidevinblastine
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT02641314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02641314.